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Abstract
Accurate identification of the DNA-binding sites of transcription factors and other DNA-binding pro-
teins on the genome is crucial to understanding their molecular interactions with DNA. Here, we describe
a new method: Genome Footprinting by high-throughput sequencing (GeF-seq), which combines in vivo
DNase I digestion of genomic DNA with ChIP coupled with high-throughput sequencing. We have deter-
mined the in vivo binding sites of a Bacillus subtilis global regulator, AbrB, using GeF-seq. This method
shows that exact DNA-binding sequences, which were protected from in vivo DNase I digestion, were
resolved at a comparable resolution to that achieved by in vitro DNase I footprinting, and this was
simply attained without the necessity of prediction by peak-calling programs. Moreover, DNase I digestion
of the bacterial nucleoid resolved the closely positioned AbrB-binding sites, which had previously
appeared as one peak in ChAP-chip and ChAP-seq experiments. The high-resolution determination of
AbrB-binding sites using GeF-seq enabled us to identify bipartite TGGNA motifs in 96% of the AbrB-
binding sites. Interestingly, in a thousand binding sites with very low-binding intensities, single TGGNA
motifs were also identified. Thus, GeF-seq is a powerful method to elucidate the molecular mechanism
of target protein binding to its cognate DNA sequences.
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1. Introduction
Genome-wide mapping of the in vivo DNA-binding
sites of transcription factors or other DNA-binding
proteins either by Chromatin Immunoprecipitation
coupled with microarray (ChIP-chip)1 or by the
recently developed ChIP coupled with high-throughput
sequencing (ChIP-seq) method have become
widely used techniques in protein–DNA interaction
research.2–5 The resolution of the DNA-binding sites
determined by ChIP-seq was a dramatic improvement
on the resolution that was possible using ChIP-chip,
because of the higher resolution of high-throughput
sequencing compared with oligonucleotide arrays.
However, for both techniques, the DNA fragments, co-
purified with the target protein (ChIP-DNA), are gener-
ated by sonication and generally fall within the size
range of 100–500 bp. These sonicated fragments are
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often much longer than the actual protein-binding site
and, thus, the sequence tags of the ChIP-DNA distribute
in broad regions around the actual binding sites. In add-
ition, as only the terminal sequences of ChIP-DNA frag-
ments can be obtained by high-throughput
sequencing, piled ChIP-seq tags on the forward (þ)
and reverse (2) strands usually show bimodal
peaks.6,7 To overcome these problems and determine
the actual protein-binding sites to within a few 10 bp,
algorithms for the processing of ChIP-seq data have
been proposed, although the results obtained by
them are still predictive.6–9 Thus, more precise experi-
mental mapping methods are required to determine
the exact binding sites of DNA-binding proteins using
ChIP-seq technology.
Recently, the ChIP-exo method, which trims the
50-region of the protein-unbound region of ChIP-
DNA by the use of 50–30 lambda (l) exonuclease,
has been developed, and this method demonstrated
an improvement in resolution in determining the
DNA-binding sites of target eukaryotic proteins
through the determination of the edge positions of
protein-bound genomic sequences.10 In contrast to
DNA exonucleases, DNase I preferentially cleaves en-
dogenous DNA regions that are not protected by
bound proteins and, thus, has been employed for in
vitro footprinting to precisely determine the DNA-
binding sites of DNA-binding proteins.11 Using
DNase I digestion, Vora et al.12 proposed a method,
designated in vivo protein occupancy display (IPOD),
which visualizes the in vivo binding profile of total
DNA-binding proteins on genomic DNA.12 In this
method, genomic DNA cross-linked with total pro-
teins and extracted from formaldehyde-treated cells
was digested with DNase I, and the DNase I-resistant
DNA fragments were purified by phenol extraction
and mapped using a tiling array.
We report here a novel method designated as
Genome Footprinting by high-throughput sequencing
(GeF-seq; in vivo GeF-seq). This method combines in
situ DNase I digestion of bacterial genomic DNA with
a modified ChIP-chip method (ChAP-chip, Chromatin
Affinity Precipitation-chip) we previously developed.13
Unlike IPOD, GeF-seq can visualize the binding profile
of a specific target protein at a resolution seen at the
in vitro footprinting level. We evaluated the resolution
achieved using the GeF-seq method by examining the
binding profile of the Bacillus subtilis transition state
regulator, AbrB, in comparison with results obtained
by ChAP-chip and a modified ChIP-seq method (ChAP
coupled with high-throughput sequencing) utilizing
sonication to fragment the genomic DNA. AbrB
represses the expression of many genes during expo-
nential growth, and we have demonstrated using
ChAP-chip that AbrB binds to hundreds of sites
throughout the entire B. subtilis genome during
exponential growth.14 AbrB is a small protein
(10.4 kDa), having a unique structure. The N-terminal
domains of two AbrB molecules form a single DNA-
binding domain, and AbrB forms a tetramer having a
stable DNA-binding ability, via both N-terminal and
C-terminal interactions. Structural modelling of AbrB
bound to the target sequence indicated that the AbrB
tetramer would interact with 20 bp sequences,15
whereas in vitro footprinting studies detected a wider
range of binding regions from 25 to 80 bp, suggesting
that a higher order structure of the AbrB tetramer may
be involved in DNA binding at some sites on the
chromosome.16–18 We previously proposed that AbrB
binds to bipartite TGGNA motifs based on the in vivo
AbrB-binding regions determined by ChAP-chip ana-
lysis,14 which is in accordance with a motif identified
by the in vitro SELEX method.17 However, the consen-
sus sequence was detected in a small number of
AbrB-binding regions, and the consensus DNA-
binding sequence for AbrB is not completely under-
stood at present.
We demonstrate here that, by mapping the
sequences of short DNA fragments co-purified with
AbrB after in situ DNase I digestion of the genomic
DNA, the AbrB-binding profile could be visualized
with a resolution comparable with that of in vitro foot-
printing. Importantly, the BiPad web server for model-
ling bipartite sequence elements19 automatically
detected consensus sequences for AbrB binding in
.95% of the experimentally determined binding
sites. Moreover, highly accurate DNA-binding site infor-
mation obtained by GeF-seq enabled us to obtain a
comprehensive view of the correlation between AbrB-
binding signals and cognate recognition sequences;
AbrB not only binds to bipartite motifs in sequences
with high binding signals, but also to single-sequence
motifs in sequences with low signals. These results
demonstrate the usefulness of the GeF-seq method.
2. Materials and methods
2.1. Bacterial strain
Bacillus subtilis strain OC001 expressing C-terminal
2HC (12 histidines plus a chitin-binding domain)-
tagged AbrB (AbrB-2HC) was used throughout.14
2.2. ChAP-chip and ChAP-seq
ChAP-chip data for AbrB binding on the B. subtilis
genome were taken from our previous report.14
DNA fragments for ChAP-seq analysis were prepared,
as previously described.13,14 Construction of the
DNA library for Illumina sequencing was as described
below except for the size of the DNA fragments used:
250 bp fragments, corresponding to 150 bp DNA
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fragments isolated by ChAP without adapter
sequences, were selected for PCR enrichment.
2.3. In situ DNase I digestion of genomic DNA
The GeF-seq method is schematically illustrated in
Fig. 1A. To cross-link protein–DNA complexes,
400 ml of OC001 (abrB-2HC) cells grown to the expo-
nential phase in Luria-Bertani medium at 378C were
treated with formaldehyde as previously described.14
To hydrolyze the cell wall without osmotic burst, cells
were treated with 5 mg/ml lysozyme in 3 ml of
isotonic sucrose-malate-magnesium buffer (0.02 M
maleic acid, 0.5 M sucrose, and 0.02 M MgCl2, pH 6.5
adjusted with NaOH)20 in the presence of 1 mM phe-
nylmethylsulfonyl fluoride (PMSF). After 20-min incu-
bation at 378C with mixing, cells were collected by
centrifugation at 6000 g for 5 min at 48C. Cells were
resuspended in 0.5 ml of a buffer containing 0.1 M
Tris–HCl (pH 7.5), 0.2 M NaCl, 1% (v/v) Triton X-
100, 0.1% (w/v) Na-deoxycholate, 0.2% (w/v) Brij
58, and 20% (v/v) glycerol.
To determine suitable conditions for in situ DNase I
digestion of genomic DNA, four samples of OC001
Figure 1. (A) Schematic workflow for GeF-seq (see Materials and methods for detail). For comparison purposes, the ChIP-chip and ChIP-seq
methods are also illustrated. (B) In situ DNase I digestion. The size of DNA fragments digested by various concentrations of DNase I
(1, 0.6, 0.4, and 0.2 U/ml, Lanes 3–6, respectively) and analysed by gel electrophoresis. DNA fragments generated by sonication are
run alongside the DNase I digested DNA for comparison purposes (Lane 2).
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cells were prepared as described above and mixed
with 10 ml of RNase A (10 mg/ml) and 50 ml of a so-
lution containing 100 mM MgCl2 and 50 mM CaCl2.
DNase I digestion was started with the addition of
0.5, 0.3, 0.2, and 0.1 units (U) of DNase I (corre-
sponding to a final concentration of 1, 0.6, 0.4, and
0.2 U/ml) (Takara) and incubated at 378C with
shaking (230 rpm) for 30 min. The reaction was ter-
minated by urea denaturation upon the addition of
3 ml of urea-Triton buffer [0.1 M 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid (pH 7.5),
0.01 M imidazole, 8 M urea, 0.5 M NaCl, 1% Triton
X-100, 10 mM b-mercaptoethanol, and 1 mM
PMSF] instead of ethylenediaminetetraacetic acid,
which severely inhibits protein purification by
Dynabeads TALON (invitrogen). The samples were
then sonicated on ice using an Astrason Ultrasonic
Processor XL (Misonix) for 10 min (4 s ‘on’ and 10 s
‘off’, at output level 5). After centrifugation to
remove cell debris, 30 ml of the supernatant was
mixed with 70 ml of M-wash buffer (0.1 M Tris–HCl,
pH 7.5, 1% sodium dodecyl sulfate, 0.01 M dithio-
threitol) and incubated at 658C overnight to reverse
the cross-linking. After the removal of proteins by
phenol–chloroform–isoamyl alcohol treatment,
DNA was recovered by ethanol precipitation in the
presence of glycogen, resuspended in 50 ml of nucle-
ase-free water and run on a 2% agarose gel (Fig. 1B).
Treatment with 0.5 units of DNase I (1 U/ml) gener-
ated DNA fragments ,100 bp in size, and incubation
with higher amounts of DNase I resulted in a decrease
in the amount of DNA detected by agarose gel elec-
trophoresis (data not shown). Thus, we selected 0.5
units (1 U/ml) of DNase I for further analysis.
2.4. Affinity purification of DNA fragments bound
to AbrB
AbrB–DNA complexes were affinity-purified from
the clarified DNase I-treated cell lysate, using
Dynabeads TALON as described previously,13,14 but
with the following modification: after protein–DNA
complexes were purified and reverse cross-linked by
heat treatment at 658C overnight, proteins were
removed using two phenol–chloroform–isoamyl
alcohol extractions, and DNA fragments were recov-
ered by ethanol precipitation in the presence of
glycogen.
2.5. Sequencing of DNA fragments co-purified
with AbrB
The DNA library for sequencing by the Illumina
Genome Analyzer IIx (GAIIx) was generated using
the NEB Next DNA Sample Prep Reagent kit (New
England BioLabs) according to manufacturer’s instruc-
tions for ‘Preparing Samples for Sequencing Genomic
DNA’ (Illumina) with the following modification; after
ligation of the adapters to the DNA fragments, the
ligated product was run on a 2% [Tris-acetate-EDTA
(TAE)] low-range agarose gel (Biorad) at 50 V for
2.5 h in TAE buffer and the region of the gel
150 bp (although the DNA was not visible on the
gel), corresponding to 50 bp fragments without
adapter sequences, was excised. The DNA fragments
were then purified using a QIAquick Gel Extraction
kit (Qaigen) and amplified using 14 cycles of PCR,
to obtain at least 1 fmol of DNA library. The amount
of DNA was determined by an Agilent 2100
Bioanalyzer using the High-Sensitivity DNA Kit
(Agilent). The sequence of the library was then deter-
mined by 75-bp single-ended sequencing using the
Illumina GAIIx sequencer according to the manufac-
turer’s instructions.
2.6. Mapping of read sequences and normalization
of tag counts
A total of 10 369 855 read sequences obtained
from the Illumina GAIIx were mapped on the refer-
ence genome (B. subtilis str. 168, NC_000964.3),
and the mapping results were visualized using the
mpsmap and psmap softwares (http://metalmine.
naist.jp/maps/gefseq), respectively.21 Because DNA
fragments of 50 bp (without adapter sequences
for PCR amplification) were selected in the sample
preparation process to obtain complete sequences of
the ChAP-DNA fragments, most of the reads reached
into the adapter sequence attached to the 30-end of
ChAP-DNA. Thus, unlike general IlluminaTM sequen-
cing results obtained by following the instruction
manual, most of the read sequences consisted of
50 bp of ChAP-DNA sequence followed by the
adapter sequence, and both of these sequences
varied in length. Since mapping of such different
lengths of sequence containing the unmappable
adapter sequence was not possible using a standard
sequence mapping/assembly program, we utilized
the property of mpsmap that maps different length
sequences to the best chromosomal location, while
allowing up to a specified number of mismatches
without a gap. In this study, the read sequences
were initially mapped allowing a maximum of 35 mis-
matches, and the adapter sequences were finally
removed. As a result of the first mapping, 9 685 519
(93%) of the read sequences were uniquely mapped
to the reference genome. (Thus, the genomic
regions encoding the 10 rRNA operons were not
included in the present analysis.) Then, to remove
the adapter sequences, the starting positions were
assigned to seven or more bases allowing a two-base
mismatch matched with 50-end of the primer se-
quence (AGATCGGAAGAGCTCGTATGCCGTCTTCTGCT
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TGA) in the 30-region of the read sequences. In
addition, mapped sequences (without adapter
sequences) with .2 bp mismatches against the refer-
ence sequence were removed, and 8 571 055 (83%)
of the read sequences remained for further analysis.
Finally, in order to normalize the difference in the
local copy number of genomic DNA, counts of
mapped reads at each nucleotide position along the
genome sequence were linearly scaled by using the
oriC/terC ratio (5.15), estimated by sequencing and
mapping of whole genomic DNA fragments digested
by DNase I, to define the AbrB-binding signals
(Supplementary Fig. S1).
Results shown in Supplementary Fig. S1 suggested
that there was preferential digestion of AT-rich
genomic sequences by DNase I. However, mapping
results of the distribution of ChAP-DNA sequences
suggested that the preferentiality apparently did not
affect the quantitative estimation of the AbrB-
binding profile (Supplementary Fig. S2).
2.7. Detection of protein-binding regions
Most of the read sequences were mapped on dis-
tinct regions along the genome surrounded by
regions where ends of the read sequences accumu-
lated (Fig. 3C). We used this feature to define the
AbrB-binding sites. To estimate the end points of the
genomic sequences in the read sequences more pre-
cisely, we reanalysed them so that adapter sequences
at the 30-ends of the sequences could be subtracted
from the genomic DNA they had been attached to
during generation of the library for sequencing. We
assigned sequences as ‘adapter sequences’ when five
bases at the 30-end of the read sequence were identi-
cal to the adapter primer sequence and the following
sequences matched to the primer sequence with no
more than two bases mismatched. The accumulation
profile of the 30-ends thus determined across the
genome sequence was similar to that of 50-ends,
which was defined as the first base of the read
sequences (Supplementary Fig. S3), strongly suggest-
ing that the procedure to estimate the 30-ends of
read sequences was reliable.
Then, the left ends of the read sequences relative to
the reference genome sequence were defined as a
sum of the 50-ends of read sequences mapped on
the plus strand and the 30-ends of read sequences
mapped on the minus strand, whereas the right
ends were defined as a sum of the 30-ends of read
sequences mapped on the plus strand and the
50-ends of read sequences mapped on the minus
strand (Supplementary Fig. S3). We counted the
numbers of left and right ends mapped to each
Figure 2. Example of AbrB-binding profiles detected by ChAP-chip, ChAP-seq, and GeF-seq on the B. subtilis genome. The distribution of
AbrB-binding sites on the B. subtilis genome is shown in the indicated genome region at the top of the figure. For the ChAP-chip
results, previously published data were used. The top, middle, and bottom lines indicate binding intensities of 7, 0.4, and 0,
respectively, as defined by the previous report.14 For ChAP-seq and GeF-seq, protein-binding intensities (number of reads after
normalization of the local copy number of the genomic DNA) are presented as a sum of binding intensities on the plus and 2
strands. The top lines in both the ChAP-seq and GeF-seq columns indicate binding intensities of 15 000 and 25 000, respectively,
and the bottom lines indicate binding intensities of 0. The gene organization is schematically shown at the bottom.
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Figure 3. Comparison of AbrB-binding sites determined by GeF-seq, ChAP-Seq, and ChAP-chip. (A) A typical example of AbrB-binding
regions that are merged into one peak in ChAP-Seq and ChAP-chip, but separately detected by GeF-seq. For the ChAP-chip results,
previously published data were used. For ChAP-seq and GeF-seq, binding intensities on the forward (þ) and reverse (2) strands are
inversely shown by transparent blue and red peaks, respectively (thus, overlapping regions appear purple) in the respective inverted
orientation (þ and 2) and their summed binding intensities are shown by a dark blue peak in the upper part of the figure
(merged). The gene organization is schematically shown at the bottom. (B) A typical example of AbrB-binding regions, where ChAP-
seq detected two peaks on the plus and minus strands with a gap, but GeF-seq detected two peaks at the same position (see Results
for details). (C) Resolution of detection within an AbrB-binding region of the chromosome by GeF-seq analysis. The intergenic
region between yqxM and yqzG in (B) is magnified. The number of left and right ends is depicted by green and red lines,
respectively, at each base. The scale for the protein-binding intensity and the number of left and right ends are indicated on the
right inside and outside, respectively, and the highest positions on the left and the right edges are marked by vertical dotted lines
whose boundaries are defined as the protein-binding region. The AbrB-binding region, which was previously determined by in vitro
footprinting,18 is also shown by green boxes in (A) and (B) and red letters in the DNA sequence on the top in (C).
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nucleotide, and positions with 10 ends of read
sequences and with the highest number of ends
within +30 bp windows were determined in 1 bp
steps, as candidates for the left and the right boundar-
ies of the DNA-binding sequences. Then, we extracted
regions surrounded by a pair of possible left and right
boundaries positioned within a range from 25 to
80 bp (considering the in vitro AbrB footprinting
results), and regions, where AbrB-binding signal in-
tensities exceeded a threshold value at more than
half of the nucleotides between them, were extracted
as AbrB-binding sites. In this study, we first extracted
AbrB-binding sequences using the signal intensity cor-
responding to the top 10th percentile of all nucleo-
tides across the genome as the threshold
(Supplementary Fig. S4). At some regions, different
combinations of boundaries surrounding the overlap-
ping sequences satisfied the criteria. In such cases, the
innermost sequences were selected as AbrB-binding
sequences for further analysis. Finally, the average of
the AbrB-binding signals within the individual
binding sequence was calculated, as the AbrB-
binding signal intensities of each binding site.
2.8. Motif analysis
AbrB-binding DNA motifs were analysed by the
BiPad web server (http://bipad.cmh.edu) for model-
ling bipartite sequence elements.19 The BiPad
program performs multiple local alignment by
entropy minimization and cyclic refinement using a
stochastic greedy search strategy, and we used the fol-
lowing settings: left half-site, gap range lengths, right
half-site, and the iteration cycles were set to 9, 0 or
1, 9, and 500, respectively. To examine the possibility
of whether the AbrB-binding motif was discovered by
chance, we selected three sets of data, each of which
consists of 300 50 bp sequences randomly selected
from the B. subtilis 168 genome sequence by the
RSA tool,22 and analysed by Bipad.
2.9. Sequencing data
Sequencing data in this study have been submitted to
the DDBJ Sequence Read Archive (DRA) and the
BioProject database under accession code DRA0
00758 and PRJDB675, respectively.
3. Results
3.1. In vivo GeF-seq
To improve the resolution of protein-binding site
determination by ChIP-seq or ChAP-seq methodolo-
gies, we attempted in situ DNase I digestion of the
cross-linked bacterial nucleoid to restrict the size of
DNA fragments co-purified with the target protein
to directly interacting sequences (Fig. 1A). We
employed B. subtilis AbrB as a model protein, whose
binding sites were recently determined by use of the
ChAP-chip method to be .600 sites scattered
across the genome.14 Exponentially growing B. subtilis
OC001 cells expressing C-terminal 2HC (12 histidines
plus a chitin-binding domain)-tagged AbrB (AbrB-
2HC) were treated with formaldehyde to stabilize
the protein–DNA interactions by cross-linking, and
the collected cells were treated with lysozyme in iso-
tonic buffer to facilitate an efficient penetration of
DNase I into cells. Then, the genomic DNA was frag-
mented to ,100 bp by the DNase I treatment, fol-
lowed by the affinity purification of the cross-linked
AbrB–DNA complexes using cobalt-coated magnetic
beads. DNA fragments co-purified with AbrB (ChAP-
DNA) were isolated after reversing the cross-linking
between proteins and DNA. As we intended to
obtain whole sequences of ChAP-DNA to avoid the
bimodal distribution of sequence tags, DNA fragments
containing 50 bp of inserted DNA, after ligation of
adapter sequences, were selected to prepare the
library for high-throughput sequencing by Illumina
GAIIx. It has been demonstrated that AbrB interacts
with 20 bp sequences15 and, thus, we also expected
that 50 bp fragments would be enough to cover single
AbrB-binding sites. Single-ended 75-bp sequencing by
the Illumina GAIIx generated 9 685 519 (uniquely
mapped) sequence reads. As expected, most of the
read sequences (88.5%) contained the adapter
sequences for PCR amplification at the 30-end
portion, with an average insert size of 50 bp after
removal of them (Supplementary Fig. S5), and insert
sequences were mapped on distinct sites on the B.
subtilis genome. Then, counts of the mapped reads
at each nucleotide position along the genome were
normalized for differences in the local copy number
of genomic DNA, to define the AbrB-binding signals.
3.2. Comparison of the distribution of AbrB-binding
signals determined by GeF-seq, ChAP-seq, and
ChAP-chip
To evaluate the resolution of the GeF-seq method
in identifying genomic protein-binding sites, we ini-
tially compared the distributions of AbrB-binding
signals along the genome as determined by three
methods: GeF-seq, ChAP-seq, and ChAP-chip. The dis-
tributions of the AbrB-binding signals on the genome
determined by GeF-seq and ChAP-seq in the present
study were highly consistent with that of ChAP-chip
we reported previously.14 Typical examples of the
comparison are presented in Fig. 2, and the complete
profiles of the binding signals across the genome
obtained by the three methods are available in
Supplementary Fig. S2. Close-up views of profiles of
AbrB-binding signals (Fig. 3A and B) indicated that,
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although the ChAP-seq method improved the reso-
lution of detection of the binding regions compared
with ChAP-chip, the GeF-seq method dramatically
improved the resolution even when compared with
ChAP-seq. Importantly, GeF-seq could resolve the
closely positioned binding sites that appear as one
peak in the ChAP-seq method, as shown in Fig. 3A.
Using ChAP-seq, binding sites were often detected
as two broad peaks on the forward (þ) and reverse
(2) strands, as previously reported.6 In contrast,
using GeF-seq, the distributions of sequence tags on
the plus and 2 strands overlapped in the middle of
the two ChAP-seq peaks (Fig. 3B). Thus, the use of
short DNA fragments enabled the conclusive deter-
mination of protein-bound regions of DNA without
the necessity for the bioinformatic prediction of the
binding sites. In addition, AbrB-binding signals at
each binding site generally distributed in a trapezoid
form, and the ends of the read sequences accumu-
lated at the left and right edges (Fig. 3C). These obser-
vations strongly suggested that in situ DNase I
digestion occurred at the boundaries of protein-
binding sites, as observed in in vitro DNase I footprint-
ing. Furthermore, the lengths of sequences protected
from DNase I digestion (27–80 bp) suggested that
these sequences would be interacting with one to
three AbrB tetramer(s). We used this feature to
define AbrB-binding sequences, as described below.
3.3. Determination of AbrB-binding sequences
To automatically extract DNA sequences bound by
AbrB from the GeF-seq results, we developed an ana-
lytical pipeline as described in Materials and methods.
Briefly, we first surveyed pairs of nucleotide positions
showing the highest accumulation of ends of read
sequences, as candidates for the borders of the
protein-binding regions. Then, AbrB-binding signals
between them were evaluated using a relaxed thresh-
old value, corresponding to the signal intensity at the
top 10th percentile of all nucleotide positions across
the genome (Supplementary Fig. S4). This resulted
in 5897 possible AbrB-binding sites being detected
(Supplementary Table S2), which included not only
specific, but also non-specific AbrB-binding, sites.
These were extracted and ranked by their average
binding signal intensities of nucleotides included in
each site. The peak ID was given from 1 to 5897 by
their intensity ranked from high to low, respectively.
The top 700 binding sites accompanied by high-
binding signal intensities were first examined,
because this number was approximately similar to
that obtained by previous ChAP-chip analysis (694
binding sites).14 The length of the AbrB-binding
regions determined by the GeF-seq ranged from 27
to 79 bp (Supplementary Fig. S6), which was consistent
with the results of in vitro footprinting experiments
listed in a database of transcriptional regulation in B.
subtilis23 and in recent reports.17,18,24 Among 32
AbrB-binding sites previously determined by in vitro
DNase I footprinting, our GeF-seq experiment detected
11 AbrB-binding sequences (Fig. 3C and
Supplementary Table S1). GeF-seq also detected 10
AbrB-binding sequences within the 5897 possible
AbrB-binding sites, although binding intensities were
lower than those of the top 700 binding sites
(Supplementary Table S1). Thus, we found that these
21 binding sites matched those obtained by in vitro
DNase I footprinting. These results indicate that our
GeF-seq method has the ability to detect protein-
bound DNA sequences with a resolution comparable
with that of the in vitro footprinting method, although
differences in boundaries are observed between our
GeF-seq result and the in vitro footprinting result,
which may result from differences in conditions
between in vivo and in vitro experiments.
3.4. Identification of consensus sequences for the
AbrB binding
In previous ChAP-chip analysis,14 we found a pos-
sible consensus sequence for AbrB binding to be
TNCCA–4 bp–TGGNA, which is composed of a pair
of two AbrB-binding motifs previously identified by
the in vitro SELEX method.17 However, those motifs
were detected in a limited number of AbrB-bound
sequences. In addition, we found that not only
TNCCA–4 bp–TGGNA, but also other bipartite
TGGNA motifs, in palindromic or tandem orientation,
separated by 4–5 bp were enriched in AbrB-bound
DNA sequences on the B. subtilis genome.
In the present GeF-seq analysis, the lengths of auto-
matically extracted AbrB-binding sequences were
restricted to an in vitro DNase I footprinting level.
Thus, we expected that the large amount of precise in-
formation on AbrB-binding sequences might give us a
clear view on the consensus AbrB-binding sequence.
We then utilized the BiPad web server, a web interface
to predict sequence elements embedded within
unaligned sequences, to analyse the experimentally
derived AbrB-binding sequences. BiPad predicts
various pairs of bipartite motifs with different gaps in
different orientations as one consensus sequence.19
BiPad successfully identified a mixture of bipartite
TGGNA motifs in 96% (678) of the 700 experimentally
identified sequences (Fig. 4A), and we found that we
could classify them into six patterns by manually
sorting the predicted consensus in each AbrB-binding
sequence (Fig. 4B and Supplementary Table S3). As a
result, consensus sequences were found to be com-
posed of bipartite TGGNA motifs separated by 4 or
5 bp AT-rich sequences arranged in direct, reverse
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direct, inverted, and everted repeat orientations
(Fig. 4B). Importantly, the location of the consensus se-
quence was usually close to the middle of the experi-
mentally identified binding sequences (Fig. 4C). Thus,
we not only confirmed that the AbrB-binding consen-
sus sequence we proposed previously was indeed de-
tectable in almost all of the AbrB-binding sequences
with high binding signals, but we also demonstrated
that the information on the protein-binding sequences
automatically extracted by the GeF-seq analysis
enabled us to clearly identify a consensus sequence
for protein binding, at least in the case of AbrB.
It should be also noted that any clear consensus se-
quence was not detected in the remaining 22
sequences, although a degenerate single TGGNA
motif was detected (data not shown). Since AbrB
Figure 4. Consensus sequences of AbrB-binding sites identified by BiPad. (A) The top 700 AbrB-binding sequences ranked by their average
binding intensity from high to low were analysed. The results of BiPad analysis were plotted regardless of the orientation of the TGGNA/
TNCCA motif; direct repeat (DI), reversed direct repeat (RDR), inverted repeat (IR), and everted repeat (ER). The number of input
sequences and sequences judged to contain the consensus sequences by the algorithms are indicated. The mixture of four types of
bipartite patterns with 4- and 5-bp spacing in (A) were sorted and the graphical logo for each pattern was re-created in (B). The DI
and RDR bipartite pattern were plotted in the same logo. The number of sequences belonging to each bipartite pattern is shown.
(C) Distribution of bipartite DNA motifs within the 700 binding sequences. The binding sequences were sorted by length, and the
motifs identified by Bipad were marked red.
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binding to these sequences was clearly detected with
high signal intensity (Supplementary Fig. S2 and
Supplementary Table S2), this result indicates that
AbrB also binds to sequences without bipartite
motifs by some mechanism, for example, when the
DNA sequence forms structure(s) to fit the AbrB-
binding surface.
3.5. Correlation between AbrB-binding signals
and motif discovery
Here, using 700 AbrB-binding DNA sequences with
high GeF-seq AbrB-binding signals, we identified bi-
partite AbrB-binding motifs across the Bacillus
genome arranged in any orientation with a 4- or 5-
bp spacing, which is consistent with our previous
ChAP-chip analysis14 and the in vitro SELEX results
reported by Xu and Strauch.17 These results strongly
suggested that, when binding signal intensities are
high, the sequences are those specifically recognized
by AbrB. We usually use a threshold value to discrimin-
ate ‘real’ protein-binding peaks and possible ‘artificial’
binding peaks in ChIP-chip and ChIP-seq experiments.
However, actually, these threshold values have been
operationally defined by researchers; for example,
aiming to remove false positives or to remove false
negatives, and examination of actual protein binding
to extract possible binding sequences has rarely been
examined thoroughly. The finding that we could iden-
tify AbrB-binding consensus sequences in almost all
of the binding sequences accompanied with high
binding signals in GeF-seq prompted us to comprehen-
sively examine whether there was conservation of the
binding motifs in sequences with lower binding signals.
To this end, we divided the 5897 possible AbrB-
binding sequences into 20 sets each containing 300
sequences, according to average AbrB-binding signal in-
tensities (Supplementary Table S2 and Supplementary
Fig. S4C), and the consensus sequence for each set was
extracted by the Bipad program (Fig. 5). In the three
datasets with the top AbrB-binding signal intensities
(1–300, 301–600, and 601–900), the bipartite
TGGNA motifs with a 4- or 5-bp spacer sequence were
detected in almost all sequences (98, 96, and 96% re-
spectively, Fig. 5). In the next group of datasets with
lower binding signal intensities (901–1200, 1201–
1500, and 1501–1800), although the consensus
sequences containing bipartite TGGNA motifs with a
4- or 5-bp spacer sequence could be detected, one
half-site became degenerate. Interestingly, in the follow-
ing 10 sets (from 1801 to 4800), only a single TGGNA
motif was detected, whereas, in the remaining four
sets with the lowest binding signal intensities (from
4801 to 5897, Fig. 5), the single motif becomes very de-
generate. We confirmed that the TGGNA motif was not
detected by chance because no motif was detected in
similar sets of DNA sequences (300 50-bp sequences)
that were randomly extracted from the genome se-
quence of B. subtilis 168 (data not shown). These
results strongly suggested that AbrB not only binds
stably, with high experimentally derived binding
signals, to bipartite TGGNA motifs, but also interacts
with single TGGNA motifs in sequences with lower but
significant experimentally derived signal intensities
(Supplementary Fig. S4).
4. Discussion
We demonstrate here that, by mapping the
sequences of 50 bp fragments co-purified with
AbrB after in situ DNase I digestion of genomic DNA,
in vivo AbrB-binding sites could be determined with
a resolution comparable with that of in vitro foot-
printing. Furthermore, comprehensive and precise in-
formation on the DNA sequences that AbrB binds gave
us a clear view of AbrB binding on the B. subtilis
genome—it would stably bind to bipartite TGGNA
motifs, but it also interacted with many single
TGGNA motifs on the genome.
In vitroDNase I footprinting has currently been one of
the most widely used methods to determine at high
resolution the precise DNA sequences bound by tran-
scription factors and other DNA-binding proteins.
However, this method is laborious and can be per-
formed against only a few DNA sequence targets in
one experiment. In addition, the synthetic conditions
under which DNase I foorprinting assays have been con-
ducted risks leading to artifactual results for several
reasons, e.g. the use of purified proteins that are not
modified as would occur in vivo and may not work in
the same way, the low-ionic strength of solutions used
in in vitro footprinting experiments that may allow
non-specific DNA–protein interactions, the use of
short DNA sequences that may lack the secondary struc-
ture of DNA found in vivo, experiments conducted at
non-physiological temperatures, and the absence of es-
sential effectors, which may impair the specific binding
of the protein to the corresponding DNA sequence. In
contrast, in the GeF-seq method, DNA–protein interac-
tions in the nucleoid are stabilized in the living cells by
formaldehyde treatment, and then DNA digestion is
carried out in situ to retain the native DNA-binding
state of the target protein. Thus, the GeF-seq method
identifies the actual DNA-binding sequences of target
proteins across the whole genome simultaneously,
with minimal risk of artefacts, and at high resolution,
which is comparable with that of in vitro footprinting.
In analysing the resolution of the method, we confirmed
that 21 AbrB-binding regions we found using GeF-seq
were consistent with in vitro footprinting results
that have been reported previously (Supplementary
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Table S1). It should also be noted that some AbrB-
binding sites previously detected by in vitro footprinting
(Supplementary Table S1) were not detected using GeF-
seq. Although it is possible that such regions might be
occupied by AbrB under some specific conditions, AbrB
binding to these DNA sequences may occur only in in
vitro experimental conditions.
Here, we detected not only bipartite TGGNA motifs
in probable high-affinity AbrB-binding sites, but also
single TGGNA motifs in possible low-affinity AbrB-
binding sites, that would be generally ignored as
non-specific, using the binding-site prediction soft-
ware. Such low-affinity AbrB binding may not be bio-
logically important, but it is possible that those
binding sites may have a role to concentrate AbrB
molecules on the nucleoid to increase the chance of
finding high-affinity binding sites, which are directly
involved in gene regulation.25 We usually use a
Figure 5. Consensus sequences of the AbrB-binding sequences detected in the top 10th percentile threshold. Each group of 300 signals in
the 20 sets of AbrB-binding sequences were ranked from high to low by binding intensities and were analysed by Bipad to detect
respective consensus sequences. The number of sequences containing the motif is shown in parallel.
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threshold value to discriminate ‘real’ protein-binding
peaks on the genome and possible ‘artificial’ binding
peaks in ChIP-chip and ChIP-seq experiments.
However, our results clearly demonstrated that the
use of threshold values could discard important infor-
mation. Our results suggest that comprehensive and
precise information on protein-binding sequences
obtained by GeF-seq analysis, in combination with
the identification of consensus sequences in them,
would give us a clear and comprehensive view of
protein binding on the genome.
Specifically, we clearly demonstrate here that the
consensus sequence for the high-affinity AbrB
binding is comprised of bipartite TGGNA motifs
gapped by a 4- or 5-bp AT-rich sequence arranged
in direct, reverse direct, inverted, and everted repeat
orientations. This result is consistent with a previous
in vitro SELEX study,17 and our informatics analysis
showing that various bipartite motifs are enriched in
AbrB-binding regions determined by ChIP-chip.14
Thus, the GeF-seq results reported here show, for
the first time, the highly flexible proposed consensus
sequences, which are actually recognized by AbrB
molecules in in vivo. Previous structural modelling of
AbrB bound to the target DNA sequence indicated
that the AbrB tetramer would interact with 20 bp
sequences,15 whereas in vitro footprinting studies
detected a wider range of binding regions from 25
to 80 bp. In this study, GeF-seq also detected a
similar range of AbrB-binding regions from 27 to
80 bp in size. When the positions of the bipartite
motifs within the binding sequences are depicted,
the motifs are usually located in the middle of the
binding sequences, but some are not centrally
located in the long binding sequences (Fig. 4C,
Supplementary Table S3). Interestingly, we observed
that the binding region is generally composed of mul-
tiple TGGNA motifs almost covering the full length of
the sequenced region (data not shown), suggesting
that higher oligomers of AbrB may interact with mul-
tiple TGGNA motifs.
Here, we have demonstrated that GeF-seq is a
powerful tool for helping to understand the in vivo
distribution of DNA-binding proteins on the
genome. However, several issues remain to be
explored, in order to fully establish the GeF-seq
method. (i) We have not yet examined how DNase I
digestion conditions would affect the results, although
the results shown in Supplementary Figs S1 and S2
suggest that the GeF-seq results would be robust
against changes in DNase I digestion conditions. (ii)
We empirically selected criteria to map read
sequences and to define protein-binding sites on the
genome. Further improvements in the sequence
data processing algorithms are desirable to automate
this process. (iii) The Bipad program outputs one
consensus sequence for each input sequence, and a
method to identify multiple motifs in each sequence
is desirable. (iv) GeF-seq data suggest that protein-
binding signal intensities to the genome should cor-
relate with protein-binding affinities to the cognate
target sequences, but this needs to be shown experi-
mentally. (v) GeF-seq has successfully determined
protein-binding sites across a bacterial genome, but
examination of whether this method is applicable for
much larger genomes of higher organisms is necessary.
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